• AMPK–SQSTM1 Feedback in Metabolic Stress

  2026-09-01

  This 2024 Autophagy study identifies a double-positive feedback loop between AMPK and SQSTM1/p62 that coordinates NFE2L2/NRF2 antioxidant signaling during metabolic stress. Its mechanistic framework connects lysosomal deacidification, KEAP1 degradation, AXIN–STK11–AMPK assembly, and TAK1-dependent p62 phosphorylation, offering a useful model for studying stress adaptation in cancer cells.

• BMS-345541 (free base): Reliable Cell Assays

  2026-08-31

  This scenario-driven guide shows how BMS-345541 (free base), SKU B4655, can improve interpretation and reproducibility in cell viability, proliferation, and cytotoxicity experiments involving NF-κB signaling. It covers concentration selection, solvent handling, controls, data interpretation, and practical vendor-selection criteria.

• BMS-345541 Hydrochloride: IKK Inhibitor Workflow

  2026-08-31

  BMS-345541 hydrochloride provides a selective way to suppress IKK/NF-κB signaling while connecting inflammatory transcription to cell-death phenotypes. This workflow shows how to use it in inflammation research, T-ALL assays, and RIPK1-centered mechanistic studies without confusing pathway inhibition with direct RIPK1 blockade.

• Anlotinib Hydrochloride: Anti-Angiogenic TKI

  2026-08-30

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor with potent VEGFR2, PDGFRβ, and FGFR1 activity. Preclinical evidence supports its use in cancer research focused on endothelial cell migration inhibition, capillary tube formation, ERK signaling, and tumor angiogenesis.

• RIPostC, Ketone Bodies, and Ferroptosis After Stroke

  2026-08-29

  A 2024 ACS Chemical Neuroscience study links remote ischemic postconditioning to increased ketone-body production and reduced ferroptotic injury after ischemic stroke. Its rat and HT22-cell experiments provide a mechanistic framework for testing ketone-body metabolism, GPX4 preservation, ACSL4 suppression, and iron handling in neuroprotection workflows.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-08-28

  This 2024 in vivo study shows that cycloastragenol limits bone loss and necrotic lesion development in a methylprednisolone-induced rat model of glucocorticoid-induced osteonecrosis of the femoral head. By combining micro-CT, angiography, histology, quantitative PCR, and Western blotting, the authors connect protection of femoral-head structure with reduced osteoclast-associated signaling and bone-resorption markers.

• Dasatinib (BMS-354825) as an EMT Research Tool

  2026-08-28

  Dasatinib (BMS-354825) provides a kinase-focused way to dissect Src, Bcr-Abl, focal adhesion, and EMT-associated phenotypes. This article connects its validated assay behavior with the SNAI1–PIK3R2/p-EphA2 findings in thymic epithelial tumors while defining practical limits for interpretation.

• Ruthenium Red in Mechanostress Autophagy

  2026-08-27

  Ruthenium Red is a versatile Ca2+ transport inhibitor for dissecting how mechanical stress, cytoskeletal organization, and autophagy intersect. This article develops an evidence-based assay framework that separates direct findings from testable calcium-signaling hypotheses.

• Reversine (A3760): Aurora Kinase Workflow

  2026-08-27

  Reversine (SKU A3760) provides a research tool for perturbing Aurora kinase signaling in mitosis-focused cell and cancer studies. This guide covers solvent preparation, controls, assay interpretation, and limitations; it should not be used for diagnostic, therapeutic, or clinical purposes.

• PD-L1–IL-6 Crosstalk in Primary Sclerosing Cholangitis

  2026-08-26

  The reference study integrates spatial proteomics with cell-cell cross-talk analysis to map a PD-L1 and IL-6 interaction at the epithelial-immune interface in human primary sclerosing cholangitis. Its main contribution is a spatially resolved framework for connecting immune-checkpoint biology with inflammatory cytokine signaling, while also defining important limits for causal and therapeutic interpretation.

• BRD4 Inhibition Primes Erastin-Induced Ferroptosis

  2026-08-26

  The reference study shows that pharmacologic or genetic BRD4 inhibition broadly sensitizes multiple cell lines to erastin-induced ferroptosis. Its central mechanistic insight is that reactive oxygen species accumulation and loss of FSP1-associated protection provide a shared explanation, despite cell-line-specific changes in other ferroptosis regulators.

• tiRNA: Controllable Gene Silencing by Translation Inhibition

  2026-08-25

  The reference study introduces tiRNA, an aptamer-based steric-blocking oligonucleotide that suppresses translation by directing an eIF4G-binding module to the 5′ untranslated region of a selected mRNA. Its reported siRNA-comparable activity, lack of RNA degradation, and neutralizing-strand reversibility position tiRNA as a potentially controllable approach for regulating disease-associated protein overexpression.

• Lipo3K Transfection Reagent for GBM Assays

  2026-08-25

  Build cleaner PXDN–LDHA perturbation experiments with a low-toxicity lipid transfection reagent designed for DNA, siRNA, mRNA, and difficult cell types. This workflow connects plasmid rescue, RNA interference, metabolic readouts, and practical troubleshooting for glioblastoma research.

• Neuroligin 1, D2-MSNs, and Repetitive Behavior

  2026-08-24

  This study identifies striatal dopamine receptor D2-expressing medium spiny neurons as a cell-type-specific circuit substrate for autistic-like repetitive behavior after Neuroligin 1 loss. By integrating behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, it links D2-MSN hyperactivation to PKC overactivation and separates the activity patterns associated with self-grooming and digging.

• BMS-345541 hydrochloride: IKK Workflows

  2026-08-24

  Use BMS-345541 hydrochloride as a selective NF-κB pathway probe for separating inflammatory transcription from RIPK1-linked cell-death decisions. This guide translates its allosteric IKK activity into practical workflows for inflammation research, T-ALL studies, and mechanism-driven cancer biology research.

8194 records 6/547 page Previous Next First page 上5页 678910 下5页 Last page